Financial Results at Ipsen | Detailed Financial Performance

Financial Results

Q3 2025 Results

Ipsen’s financial results for the first nine months of 2025 were published on 22 October 2025.

An investor and analyst conference call took place on the same day.

Learn more

Period

recent search

Reset

Showing: 1 – 05 of 31 Financial Results

Ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance
 –  27 April 2023

27 April 2023

Download
Ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance

Paris (France), 27 April 2023


Ipsen presents strong full-year 2022 results and guidance for 2023
 –  09 February 2023

09 February 2023

Download
Ipsen presents strong full-year 2022 results and guidance for 2023

Paris (France), 9 February 2023


Ipsen delivers strong sales growth in the first nine months of 2022 and confirms its full-year guidance
 –  27 October 2022

27 October 2022

Download
Ipsen delivers strong sales growth in the first nine months of 2022 and confirms its full-year guidance

Paris (France), 27 October 2022


Ipsen delivers strong H1 2022 results and upgrades its full-year guidance
 –  28 July 2022

28 July 2022

Download
Ipsen delivers strong H1 2022 results and upgrades its full-year guidance

Paris (France), 28 July 2022 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, presents its financial results for the first half of 2022:


Ipsen delivers a strong sales performance in the first quarter of 2022
 –  27 April 2022

27 April 2022

Download
Ipsen delivers a strong sales performance in the first quarter of 2022

Attachment


Your dedicated contacts